BB Biotech AG (0JYO.L)

58.54 -0.41 (-0.70%) At close: 05:11PM BST

BB Biotech AG

Seestrasse 16
Küsnacht CH-8700
Switzerland
41 44 2676700
https://www.bbbiotech.ch/en/bb-biotech/

Sector(s): 
Industry: 
Full-time employees: 10

Description

BB Biotech AG is an equity fund launched and managed by Bellevue Asset Management AG. The fund invests in the public equity markets across the globe. It primarily invests in stocks of companies that are engaged in medications and diagnostics based on modern biotechnology. The fund employs a fundamental analysis to create its portfolio. BB Biotech AG was formed on November 09, 1993 and is domiciled in Switzerland.

Corporate governance

BB Biotech AG’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.